drugset / Trial / NCT04094467

Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection

NCT04094467

Phase 4 Unknown 150 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

Stein and Leventhal were the first to recognize an association between the presence of polycystic ovaries and signs of hirsutism and amenorrhea (eg,oligomenorrhea, obesity), After women diagnosed with Stein-Leventhal syndrome underwent successful wedge resection of the ovaries, their menstrual cycles became regular, and they were able to conceive. As a consequence, a primary ovarian defect was thought to be the main culprit, and the disorder came to be known as polycystic ovarian disease.

Timeline

Start
2019-12-07
Primary completion
2020-10
Completion
2021-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Leuprolide Other / unclassified 0.1 mg Subcutaneous
Background Cetrorelix Other / unclassified 0.25 mg Subcutaneous